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Considered a global health crisis by The World Health Organization, hypertension (HTN) is the 
leading risk factor for death and disability. The majority of treated patients do not attain evidence-
based clinical targets, which increases the risk of potentially fatal complications. HTN is the most 
common chronic condition seen in primary care; thus implementing therapies that lower and 
maintain BP to within target ranges is of tremendous public health importance. Isometric handgrip 
(IHG) training is a simple intervention endorsed by the American Heart Association as a potential 
adjuvant BP-lowering treatment. With larger reductions noted in HTN patients, IHG training may 
be especially beneficial for those who a) have difficulties continuing or increasing drug-based 
treatment; b) are unable to attain BP control despite optimal treatment; c) have pre-HTN or low-
risk stage I mild HTN; and, d) wish to avoid medications or have less pill burden. IHG training is 
not routinely prescribed in clinical practice. To shift this paradigm, we focus on: 1) the challenges 
of current HTN management strategies; 2) the effect of IHG training; 3) IHG prescription; 4) 
characterizing the population for whom it works best; 5) clinical relevance; and 6) important next 












Hypertension (HTN), defined as a systolic blood pressure (BP) ≥ 140 mmHg and/or a diastolic BP 
≥ 90 mmHg, is a global epidemic [1]. It is the leading cause of cardiovascular disease (CVD) and 
related mortality worldwide [2-5], and is responsible for ~10 million deaths each year [6], making 
it a substantial contributor to global chronic disease burden [7;8].  
 
HTN is now the most commonly diagnosed condition in primary care [9-11], yet between 50 - 70% 
of patients are not controlled to within clinical target ranges [12-18]. In the United States, 
approximately 34% of adults have HTN [4], with African Americans, and particularly African 
American women, having among the highest rates of HTN in the world [2;4]. Approximately 14% 
of American patients have true “resistant HTN” [4], which is a failure to effectively reduce BP to 
recommended levels despite compliance to optimal treatment [19].  
 
Uncontrolled HTN is associated with a number of sequelae that are damaging to the 
cardiovascular system [20-29]. Long-term and potentially fatal pressure-related complications 
include coronary artery disease, heart failure, stroke, and renal failure, in addition to cognitive 
decline [1;30-33] and overall poor quality of life [34]. A recent call suggests increasing efforts to 
lower BP in individuals with resting BP between 110 - 140 mmHg (pre-HTN) to reduce the global 
HTN burden [7]. However, while HTN prevention and treatment are global health priorities for the 
World Health Organization [35;36], there is a lack of consensus on if and when antihypertensive 
therapy should be used in those with pre-HTN, making potential non-pharmaceutical alternatives 




The Challenges of Current Hypertension Management Strategies 
The objective of HTN-related clinical practice, in general, is to achieve a resting BP of ≤ 140/90 
mmHg [10;12;37-42] using traditional office based oscillometric measurements, or ≤ 135/85 
mmHg using newer, unattended automated office BP measurement devices [38;43]. However, 
these guidelines are always evolving and will likely become more stringent by lowering BP goals 
in the near future, at least for higher risk patients [7;10]. Adherence to HTN medication, a modified 
diet (e.g., sodium and alcohol reduction, Dietary Approaches to Stop Hypertension (DASH) eating 
plan), and increased physical activity are frontline components of BP management [44;45]. With 
respect to the latter, international guidelines overwhelmingly recommend aerobic exercise training 
with dynamic resistance training as an adjuvant intervention [38;44-47].  
 
Despite the existence of these well-publicized management guidelines, non-compliance is 
common. Less than 50% of patients adequately adhere to their HTN medication regimen [48;49] 
for a myriad of reasons including sociocultural and economic considerations, and risk for non-
compliance is particularly high in African Americans [50]. Further, adherence to dietary strategies 
is remarkably poor [47], and almost half of American adults are inactive (with even higher rates 
of inactivity reported among African Americans and those living in poverty) [51]. Common barriers 
to exercise include physical and other health limitations, lack of convenience, competing priorities 
and access difficulties [52-54]; these may extend to include an absence of social support, 
inflexible work schedules, unattainable costs and unsafe exercise environments [55-58].  
 
In light of the above-noted realities, it is imperative to acknowledge that long-term compliance 
with traditional BP-lowering treatments is poor [47]. Thus, complementary treatments that can 
successfully reduce and maintain BP to within clinical targets are urgently needed, particularly for 
those that have a high potential for uptake and continuation over long periods of time. 
Alternative Hypertension Treatments: Use of Isometric Handgrip Training as a Non-
Pharmacological Approach to Blood Pressure Management 
A plethora of “alternative”, non-pharmacological complementary approaches to BP lowering have 
been investigated over the years, and have been implemented in patient cohorts ranging from 
pre- to resistant-HTN [47]. Falling broadly into three main categories, these alternative 
approaches include behavioral strategies (e.g., meditation, biofeedback), non-invasive 
procedures or devices (e.g., device-guided slow breathing, acupuncture), and novel exercise-
based interventions (e.g., isometric handgrip (IHG) training) [47]. In their Scientific Statement on 
Alternative Approaches to Lowering Blood Pressure, the American Heart Association (AHA) 
supported the use of biofeedback techniques, device-guided breathing and IHG training as 
potentially effective BP-lowering adjuvant therapies, and amenable for use in clinical practice [47]. 
For the purposes of this report, we focus our attention on IHG training.  
 
The weight of the evidence suggests that IHG training, a form of isometric resistance training 
comprised of multiple sustained forearm contractions separated by short rest periods, is a safe, 
simple, and easily-adoptable intervention to lower BP. The most recent meta-analysis of 
randomized controlled isometric resistance training trials (RCTs; N=302) cites post-training 
reductions in resting BP of ~5/4 mmHg, with larger reductions noted in HTN patients [59]. Early 
evidence suggests that ambulatory BP, a superior measure for diagnostic and prognostic 
purposes [60-63], may also be reduced. In the only trials involving ambulatory BP measurement, 
statistically significant reductions in mean 24-hour systolic BP were observed in young healthy 
adults following IHG training [64], while a clinically relevant post-training reduction was noted in a 
population of well-controlled HTN patients [65].  
 
The time-efficient IHG protocol lasts as little as 12 minutes (11 if you discount the last minute of 
rest), and has proven effective in individuals with and without HTN (even in medicated 
hypertensives) and those who are already physically active [65-84]. Importantly, IHG training is 
well-tolerated by participants, and seems to present low levels of risk to safety. High compliance 
rates have been reported across isometric resistance training trials and there have been no 
published reports of acute or long-term adverse events [59;80]. While some clinicians may be 
concerned about the potential safety of IHG, current data supports only modest transient on-
exercise increases in heart rate (∆ 3-8 bpm) and BP (∆ 12-38/7-23 mmHg) for most people studied 
thus far, even in those with pre-HTN and HTN [74;80;85-88]. Acute HR and BP changes are less 
than those elicited during moderate and vigorous aerobic exercise [88]. However, resistant 
hypertensives with more severe HTN (>160-180/100-110 mm Hg) may need to exert some 
caution because of the possible acute BP elevations during IHG, until its safety is established in 
this group. This is consistent with existing precautionary recommendations regarding the 
avoidance of aerobic exercise among these patients. 
 
Plausible BP-lowering mechanisms supported by prior trials include: improved neural cardiac 
control (e.g., heart rate variability [71;73]), augmented arterial compliance and vascular function 
[68;80;85], reduced sympathetic outflow [73], and/or an enhanced oxidative capacity [82].  
Isometric Handgrip Training Prescription 
The most common isometric resistance training protocol consists of four, 2-minute periods of 
sustained isometric exercise, separated by brief 1-minute rest periods, performed 3 to 5 times per 
week for up to 10 weeks on a handgrip dynamometer. Historically, training sessions have been 
conducted in laboratory settings, or via a combination of in-laboratory and at-home training. 
Recently completed pilot work from our group provides evidence, using a randomized single-blind 
study in HTN patients, that IHG training is feasible and effective when prescribed in clinical 
settings using a home-based model. 
 
IHG training trials have employed handgrip dynamometers ranging from computerized 
programmable devices to spring-loaded investigator calibrated handgrips, with the most widely 
studied to date in HTN patients being the former [59;80]. As the computerized devices are 
expensive, the financial burden of which may hinder patient uptake, a host of studies are being 
conducted to investigate cheaper and more readily available alternatives (e.g., stress ball, 
mechanical handgrips).               
  
While the literature on the effectiveness of IHG training is still accumulating, handgrip resistance 
training was mentioned in the 2016 Canadian Hypertension Education Program guidelines, and 
as noted above, IHG training was featured in the AHA Scientific Statement as a potentially viable 
BP-lowering option [38;47]. In their Statement, the AHA provided an “Algorithm for implementing 
alternative approaches in clinical practice” which can be applied to IHG training prescription in 
clinical practice (Figure 1). 
For Which Patients Does it Work Best? 
As with most BP-lowering treatments, IHG training appears to be particularly effective in those 
with higher initial resting BP [67;70;81]. In patients with HTN, data suggest that higher initial 
systolic BP elicits greater post-IHG training reductions [67;81]. Older individuals, and those with 
high pre-training systolic BP reactivity to cardiovascular stress tasks (e.g., serial subtraction task, 
2-minute IHG task) also appear highly responsive to IHG training [67;70;77;89;90]. African 
Americans exhibit higher BP reactivity than other populations [91] and thus, IHG training may be 
particularly beneficial in this patient population. Data focused specifically on this population group, 
however, is lacking. The effect of gender is also unclear [59;64;70] and may simply reflect the 
small overall number of women that have participated in IHG training trials to date. 
Clinical Significance 
IHG training involves the use of a portable hand-held device, is of low time burden, is highly 
tolerable and requires no “refills” or other active maintenance efforts. Thus, this treatment is likely 
to be as attractive to HTN patients as it has been to research participants. From a provider 
perspective, prescribing an effective intervention that is safe, and one to which patients have a 
great likelihood to comply, is also enticing. With larger post-training reductions noted in HTN 
patients, IHG training may be especially beneficial for patients who a) have difficulties continuing 
or increasing drug-based treatment care; b) are unable to attain BP control despite optimal 
treatment; c) have pre-HTN or low-risk stage I mild-HTN, and; d) who wish to avoid medications 
or have less anti-hypertensive pill burden.  
 
Taken together, this simple treatment has strong potential to impact patient care and improve the 
rates of BP control among those with HTN. It is important to acknowledge, however, that a post-
IHG training reduction of ~5/4 mmHg may not be enough to lower BP to within recommended 
targets (or within ~10 mmHg of target) for some patients. In these individuals, IHG training may 
be more appropriate as part of a broader lifestyle approach, with the effects of IHG training adding 
to the effects of other lifestyle modifications. The effectiveness of this type of multi-modal 
intervention trial would need to be explored in future IHG training trials.  
 
Despite its promise, IHG training is not routinely prescribed in clinical practice as a BP-lowering 
management strategy. This critical gap may be indicative of clinicians being unaware of IHG 
training or how to prescribe it, a lack of confidence in the ability of the patients to train at home, 
uncertainty about how to purchase the training devices and concern relating to the associated 
cost. The aim of this report is to take the first steps towards addressing this gap, in an effort to 
shift this paradigm. 
Important Next Steps 
In their 2017 Heart Disease and Stroke Statistics Update, the AHA stated that “the elimination of 
HTN is projected to have a larger impact on CVD mortality than the elimination of all other risk 
factors among females, and all except smoking among males” [4]. It is our over-arching goal to 
improve BP control and reduce the burden of HTN by incorporating IHG training as part of a 
comprehensive treatment strategy in clinical practice. Most IHG training studies to date have been 
small, short duration, proof-of-concept trials. Large-scale, high quality RCTs of longer duration 
are urgently needed to address these earlier limitations and further establish the merits of this 
effective treatment. Future work should aim to explore the potential additive effects of IHG training 
to traditional lifestyle modifications (e.g., DASH diet, aerobic exercise training), medical practice 
and home-based effectiveness models of IHG training, including trials in patients with resistant 
HTN and pre-HTN/mild-HTN wishing to avoid medication. Moreover, trials investigating the long-
term persistence of BP-lowering, training interventions using less expensive handgrip devices, 
and those evaluating population-specific BP-lowering mechanisms, patient and physician burden, 
clinical outcomes, and economic benefit are also needed. 
Conclusion 
Poor BP control puts many Americans and individuals around the world at risk for serious and 
often fatal complications of HTN. African Americans are disproportionately affected as are all 
individuals with treatment-resistant HTN. There is an urgent need to translate effective BP-
lowering therapies, such as IHG training, into standard care that act alone or as an adjunct to 
traditional treatments. By increasing the proportion of patients achieving BP control, we take an 
important step towards reducing the burden of HTN in our country and beyond. 
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Figure 1.  Algorithm for implementing alternative approaches in clinical practice (Brook R, Appel 
L, Rubenfire M, Ogedegbe G, Bisognano J, Elliott W, Fuchs F, Hughes J, Lackland D, Staffileno 
B, Townsend R, Rajagopalan S: Beyond medications and diet: Alternative approaches to lowering 
blood pressure. A scientific statement from the American Heart Association. Hypertension 
2013;61:1360-1383). Reprinted with permission from Wolters Kluwer Health, Inc. 
 
